基础研究

莱菔硫烷下调PI3K/Akt信号通路对高糖诱导人血小板凋亡的保护作用

  • 张春梅 ,
  • 黄新惠 ,
  • 胡锦秋 ,
  • 毕晓艳 ,
  • 牙甫礼
展开
  • 1.大理大学公共卫生学院,实验教学中心,(云南 大理 671000 )
    2.大理大学公共卫生学院,营养与食品卫生学教研室,(云南 大理 671000 )

收稿日期: 2024-06-05

  网络出版日期: 2024-09-30

基金资助

国家自然科学基金项目(82260638);云南省基础研究专项面上项目(202401AT070081)

Sulforaphane protects human platelets from high glucose⁃induced cellular apoptosis through down-regulating PI3K/Akt signaling pathway

  • Chunmei ZHANG ,
  • Xinhui HUANG ,
  • Jinqiu HU ,
  • Xiaoyan BI ,
  • Fuli. YA
Expand
  • Department of laboratory teaching center,School of Public Health,Dali University,Dali 671000,China

Received date: 2024-06-05

  Online published: 2024-09-30

摘要

目的 探讨莱菔硫烷(sulforaphane, SFN)对高糖(high glucose, HG)诱导人血小板凋亡的保护作用及机制。 方法 将不同浓度(5、10、20 μmol/L)的SFN或溶剂对照(0.05% DMSO)与健康人纯化血小板在体外共同孵育40 min,然后加入normal glucose(NG, 5 mmol/L)或HG(25 mmol/L)的葡萄糖溶液干预血小板90 min,用流式细胞术检测血小板线粒体膜电位(ΔΨm)去极化、磷脂酰丝氨酸(phosphatidylserine, PS)暴露和胞内总活性氧(reactive oxygen species, ROS)生成水平,用蛋白免疫印迹法检测PI3K、Akt蛋白磷酸化水平。 结果 与NG组相比,HG可显著增加血小板ΔΨm去极化和PS暴露水平(P < 0.001),且可被不同浓度的SFN显著抑制(P < 0.001)。机制上,与溶剂对照组相比,SFN显著下调HG诱导的血小板PI3K(P < 0.01)和Akt(P < 0.05)蛋白的磷酸化水平,显著降低HG诱导的胞内总ROS生成水平(P < 0.001);PI3K的特异性激动剂740 Y-P可完全逆转SFN对HG诱导的PI3K和Akt蛋白磷酸化的抑制作用,部分逆转SFN对总ROS生成、ΔΨm去极化和PS暴露的抑制作用。 结论 SFN在体外具有保护HG诱导健康人血小板凋亡的作用,其作用机制可能是下调PI3K/Akt介导的信号通路。

本文引用格式

张春梅 , 黄新惠 , 胡锦秋 , 毕晓艳 , 牙甫礼 . 莱菔硫烷下调PI3K/Akt信号通路对高糖诱导人血小板凋亡的保护作用[J]. 实用医学杂志, 2024 , 40(18) : 2530 -2536 . DOI: 10.3969/j.issn.1006-5725.2024.18.004

Abstract

Objective To investigate the protective effects of Sulforaphane (SFN) against high glucose (HG)?induced human platelet apoptosis and elucidate the underlying mechanisms in vitro. Methods Purified platelets obtained from healthy individuals were pre?incubated with various concentrations of SFN (5, 10, or 20 μmol/L) or a vehicle control (0.05% DMSO) for 40 minutes at 37 ℃. Subsequently, the platelets were stimulated with normal glucose (NG, 5 mmol/L) or high glucose (HG, 25 mmol/L) for an additional duration of 90 minutes. Flow cytometry was employed to assess platelet mitochondrial membrane potential depolarization (Δψm), exposure of phosphatidylserine (PS), and generation of total intraplatelet reactive oxygen species (ROS). Phosphorylation levels of PI3K and Akt were determined using Western blot. Results Compared to NG?treated human platelets, HG significantly induced depolarization of platelet Δψm and exposure of PS (P < 0.001). These effects of HG were markedly attenuated by various concentrations of SFN (P < 0.001). Mechanistically, SFN down?regulated the phosphorylation levels of PI3K (P < 0.01) and Akt (P < 0.05), which were increased by HG when compared to the vehicle control, and substantially reduced total intracellular ROS levels (P < 0.001). The inhibitory effects of SFN on HG?induced phosphorylation of PI3K and Akt, as well as its efficacy on total intracellular ROS generation, Δψm depolarization, and PS exposure in HG?stimulated human platelets were completely reversed by a specific agonist for PI3K, 740 Y?P. Conclusions The current study demonstrates that SFN exerts a protective effect on platelet apoptosis induced by HG, potentially through the down?regulation of the PI3K/Akt?mediated pathway in human platelets in vitro. These findings suggest that SFN may hold promise for improving thrombosis in diabetes mellitus and related chronic metabolic diseases.

参考文献

1 胡盛寿, 王增武. 《中国心血管健康与疾病报告2022》概述[J]. 中国心血管病研究, 2023, 21(7):577-600.
2 PICHE M E, TCHERNOF A, DESPRES J P. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases[J]. Circ Res, 2020, 126(11):1477-1500. doi:10.1161/circresaha.120.316101
3 叶健华,赵玉钏. 2型糖尿病缓解标准与治疗策略[J]. 实用医学杂志, 2023, 39(14):1729-1732. doi:10.3969/j.issn.1006-5725.2023.14.001
4 TANG W H, STITHAM J, JIN Y, et al. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets[J]. Circulation, 2014, 129(15):1598-1609. doi:10.1161/circulationaha.113.005224
5 EL-HAOUARI M. Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients[J]. Curr Med Chem, 2019, 26(22):4145-4165. doi:10.2174/0929867324666171005114456
6 SNIR O, WILSGARD L, LATYSHEVA N, et al. Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism[J]. J Thromb Haemost, 2022, 20(4):899-908. doi:10.1111/jth.15638
7 LEE S H, DU J, STITHAM J, et al. Inducing mitophagy in diabetic platelets protects against severe oxidative stress[J]. EMBO Mol Med, 2016, 8(7):779-795. doi:10.15252/emmm.201506046
8 JOSEFSSON E C. Platelet intrinsic apoptosis[J]. Thromb Res, 2023, 231:206-213. doi:10.1016/j.thromres.2022.11.024
9 张承启,李易姿,吴琪俊,等. 膳食多样化与代谢综合征关系的研究进展[J]. 实用医学杂志, 2022, 38(15):1970-1974. doi:10.3969/j.issn.1006-5725.2022.15.022
10 MEN X, HAN X, OH G, et al. Plant sources, extraction techniques, analytical methods, bioactivity, and bioavailability of sulforaphane:a review[J]. Food Sci Biotechnol, 2024, 33(3):539-556. doi:10.1007/s10068-023-01434-7
11 MAGNER M, THOROVA K, ZUPOVA V, et al. Sulforaphane Treatment in Children with Autism:A Prospective Randomized Double-Blind Study[J]. Nutrients, 2023, 15(3):718.
12 刘小明,周葳,杨补. 莱菔硫烷抑制前列腺癌细胞增殖及迁移的实验研究[J]. 实用医学杂志, 2019, 35(9):1383-1387.
13 ZHOU X, HUANG X, WU C, et al. Sulforaphane attenuates glycoprotein VI-mediated platelet mitochondrial dysfunction through up-regulating the cAMP/PKA signaling pathway in vitro and in vivo[J]. Food Funct, 2023, 14(8):3613-3629. doi:10.1039/d2fo03958c
14 李玮琪, 马永洁, 黄新惠, 等. 莱菔硫烷对ox-LDL诱导血小板活化的抑制作用[J].南京医科大学学报(自然科学版), 2023, 43(5):684-690.
15 LI W, MA Y, ZHANG C, et al. Tetrahydrocurcumin Downregulates MAPKs/cPLA2 Signaling and Attenuates Platelet Thromboxane A2 Generation, Granule Secretion, and Thrombus Growth[J]. Thromb Haemost, 2022, 122(5):739-754. doi:10.1055/s-0041-1735192
16 马永洁, 李玮琪, 伍春婷, 等. 三七总皂苷对ox-LDL诱导血小板凋亡的保护作用及机制研究[J]. 大理大学学报, 2023, 8(2):1-7.
17 曲云霄,蒋知新,韩腾龙,等. 血小板参数及活化标志物与2型糖尿病患者颈动脉内膜中层厚度的相关性[J]. 实用医学杂志, 2016, 32(8):1250-1253.
18 ARRIAGADA-PETERSEN C, FERNANDEZ P, GOMEZ M, et al. Effect of advanced glycation end products on platelet activation and aggregation:a comparative study of the role of glyoxal and methylglyoxal[J]. Platelets, 2021, 32(4):507-515. doi:10.1080/09537104.2020.1767770
19 INDANA H A, PUSPITAWATI I, MAYASARI D S, et al. Association of Acute Hyperglycemia and Diabetes Mellitus with Platelet-derived Microparticle(PDMP) Levels During Acute Myocardial Infarction[J]. J ASEAN Fed Endocr Soc, 2023, 38(2):35-40. doi:10.15605/jafes.038.02.03
20 RIVAS-GARCIA L, QUINTANA-NAVARRO G M, ALCALA-DIAZ J F, et al. Association between Diet Quality and Risk of Type 2 Diabetes Mellitus in Patients with Coronary Heart Disease:Findings from the CORDIOPREV Study[J]. Nutrients, 2024, 16(8):1249. doi:10.3390/nu16081249
21 WEI X, ZOU H, ZHANG T, et al. Gestational Diabetes Mellitus:What Can Medical Nutrition Therapy Do?[J]. Nutrients, 2024, 16(8):1217. doi:10.3390/nu16081217
22 BAHADORAN Z, TOHIDI M, NAZERI P, et al. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial[J]. Int J Food Sci Nutr, 2012, 63(7):767-771. doi:10.3109/09637486.2012.665043
23 MTHEMBU S X H, MAZIBUKO-MBEJE S E, MOETLEDIWA M T, et al. Sulforaphane:A nutraceutical against diabetes-related complications[J]. Pharmacol Res, 2023, 196:106918. doi:10.1016/j.phrs.2023.106918
24 MOHAMADI N, BARADARAN RAHIMI V, FADAEI M R, et al. A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications[J]. Inflammopharmacology, 2023, 31(6):2885-2899. doi:10.1007/s10787-023-01373-z
25 PAUL M, HEMSHEKHAR M, KEMPARAJU K, et al. Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity[J]. Free Radic Biol Med, 2019, 130:196-205. doi:10.1016/j.freeradbiomed.2018.10.453
26 YA F, LI K, CHEN H, et al. Protocatechuic Acid Protects Platelets from Apoptosis via Inhibiting Oxidative Stress-Mediated PI3K/Akt/GSK3beta Signaling[J]. Thromb Haemost, 2021, 121(7):931-943. doi:10.1055/s-0040-1722621
27 LUANG-IN V, NARBAD A, NUENO-PALOP C, et al. The metabolism of methylsulfinylalkyl- and methylthioalkyl-glucosinolates by a selection of human gut bacteria[J]. Mol Nutr Food Res, 2014, 58(4):875-883. doi:10.1002/mnfr.201300377
28 VEERANKI O L, BHATTACHARYA A, MARSHALL J R, et al. Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli:implications for cancer prevention[J]. Br J Nutr, 2013, 109(1):25-32. doi:10.1017/s0007114512000657
29 HU R, HEBBAR V, KIM B R, et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat[J]. J Pharmacol Exp Ther, 2004, 310(1):263-271. doi:10.1124/jpet.103.064261
30 NEGRETTE-GUZMAN M, HUERTA-YEPEZ S, TAPIA E, et al. Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis[J]. Free Radic Biol Med, 2013, 65:1078-1089. doi:10.1016/j.freeradbiomed.2013.08.182
31 BARALIC K, ZIVANOVIC J, MARIC D, et al. Sulforaphane-A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies[J]. Antioxidants(Basel), 2024, 13(2):147.
32 CHUANG W Y, KUNG P H, KUO C Y, et al. Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway[J]. Thromb Haemost, 2013, 109(6):1120-1130. doi:10.1160/th12-09-0636
文章导航

/